Mothercare Plc : Holding(s) in Company Amendment
Mothercare Plc : Holding(s) in Company Amendment | For filings with the FCA include the annex | |
| For filings with issuer exclude the annex | |
| |
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
| | |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Mothercare Plc |
| 2 Reason for the notification (please tick the appropriate box or boxes): |
| An acquisition or disposal of voting rights | X |
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |
| An event changing the breakdown of voting rights | |
| Other (please specify): | | |
| 3. Full name of person(s) subject to the notification obligation: iii | Jupiter Asset Management Limited |
| 4. Full name of shareholder(s) (if different from 3.):iv | Nortrust Nominees Limited Chase Nominees Limited BNY Mellon Nominees Limited |
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 5th October 2016 |
| 6. Date on which issuer notified: | 6th October 2016 |
| 7. Threshold(s) that is/are crossed or reached: vi, vii | Above 5% |
| 8. Notified details: |
| A: Voting rights attached to shares viii, ix |
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction |
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x |
| Direct | Direct xi | Indirect xii | Direct | Indirect |
| Ordinary Shares | Below 5% | Below 5% | N/A | N/A | 10,381,617 | N/A | 6.07% |
| GB0009067447 |
| |
| B: Qualifying Financial Instruments |
| Resulting situation after the triggering transaction |
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
| Securities Lending | N/A | N/A | 18,383 | 0.01% |
| |
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
| Resulting situation after the triggering transaction |
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx |
| N/A | N/A | N/A | N/A | N/A | Nominal | Delta |
| | |
| |
| Total (A+B+C) |
| Number of voting rights | Percentage of voting rights |
| 10,400,000 | 6.08% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
| The shares are held in the name of Jupiter Asset Management Limited ('Jupiter') |
| |
| Proxy Voting: |
| 10. Name of the proxy holder: | N/A |
| 11. Number of voting rights proxy holder will cease to hold: | N/A |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A |
| |
| 13. Additional information: | |
| 14. Contact name: | Lucy Wood |
| 15. Contact telephone number: | 020 3817 1231 |
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Top 5 Most Recently Viewed Articles
Acurx Pharmaceuticals Secures EMA Approval for Pediatric Trials The Pediatric Committee (PDCO) of the European Medicines Agency has recently issued a positive opinion regarding Acurx Pharmaceuticals' Pediatric Investigation Plan (PIP). This plan focuses on the use of ibezapolstat as a treatment option for children suffering from C. difficile infections. With this...
Continue Reading
Understanding Current Market Dynamics In recent discussions surrounding economic trends, investors are facing a pivotal moment. Ruchir Sharma has pointed out a significant shift in investor sentiment that may unravel in the near future. As he suggests, there could be a critical demand for higher interest rates or a demonstration of fiscal responsibility, triggering...
Continue Reading
Hewlett Packard Experiences Stock Drop After New Stock Offering Hewlett Packard Enterprise (NYSE: HPE) has recently made headlines with a significant announcement that has affected its stock performance. In after-hours trading, the company's shares dropped by 6.4% following the revelation of plans for a mandatory convertible preferred stock offering valued at $1.35...
Continue Reading
Understanding the Recent Developments Surrounding MoonLake Immunotherapeutics MoonLake Immunotherapeutics, traded on NASDAQ under the ticker MLTX, has recently found itself in a challenging situation. Investors who suffered financial losses are being urged to consider their options as the company navigates through a class-action lawsuit concerning alleged securities...
Continue Reading
Transforming AI Inferencing with Achronix Semiconductor Achronix Semiconductor Corporation is paving the way for a new era in artificial intelligence (AI) inferencing through its groundbreaking work with field-programmable gate arrays (FPGAs). Collaborating with industry leaders like Google and Myrtle.ai, Achronix is hosting a LinkedIn Live Webinar titled "The Rise of...
Continue Reading
